Overview
Next-generation sequencing (NGS) technology allows Chemisys Laboratories to analyze vast stretches of genetic material simultaneously — delivering deeper diagnostic insight than any traditional testing method.
From cancer biomarker profiling to infectious disease identification, NGS enables earlier detection, greater accuracy, and smarter treatment pathways.
Why it matters
Clinical value
CLIA-certified quality
Rigorous quality controls and validated bioinformatics pipelines.
Clinically-oriented reporting
Clear reports designed for same-week clinical decisions where possible.
Fast relative turnaround
Optimized against test complexity to support provider workflows.
Scientific support
Dedicated scientific support for result interpretation.
Applications
Clinical settings we serve
- Oncology panels — tumor mutation profiling, biomarker identification for targeted therapy
- Infectious disease — comprehensive pathogen identification including rare and emerging pathogens
- Pharmacogenomics — comprehensive drug metabolism gene profiling
- Hereditary disease screening
- Microbiome analysis
Related services
Explore more
PGx
Genetic testing that reveals how a patient processes medications — reducing trial-and-error prescribing across 55+ clinically relevant genes.
Learn moreInfectious Disease
Advanced molecular diagnostics that deliver faster, more specific pathogen identification than traditional culture.
Learn moreBlood Testing
Comprehensive blood panels and advanced specialized testing — from annual wellness exams to complex diagnostic evaluations.
Learn more